PBLS
NASD Parabilis Medicines, Inc.$28.09 ↑ +0.00 (+0.00%) Trading Up from the previous close of $28.09, $0.81 below the day’s high of $28.90
- YTD change
- -11.11%
- vs 20-day SMA
- -17.55%
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
-3.51 (-11.11%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 33.9% away from all-time highs of $42.49
- PBLS is down 11% since the beginning of the year
- PBLS is down 11% over the past 12 months
- PBLS is down 28% over the past 1 month
- 8% of all PBLS investors are betting against PBLS
PBLS reads poor: the 12-month move is -11.1%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -13.01%
- vs 8-day SMA
- -8.17%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.